HK1047103B - 喹啉羧酸衍生物或其鹽 - Google Patents

喹啉羧酸衍生物或其鹽

Info

Publication number
HK1047103B
HK1047103B HK02108684.2A HK02108684A HK1047103B HK 1047103 B HK1047103 B HK 1047103B HK 02108684 A HK02108684 A HK 02108684A HK 1047103 B HK1047103 B HK 1047103B
Authority
HK
Hong Kong
Prior art keywords
salts
acid derivative
quinolinecarboxylic acid
extremely high
ethylaminoazetidin
Prior art date
Application number
HK02108684.2A
Other languages
English (en)
Other versions
HK1047103A1 (en
Inventor
矢崎明
新野良子
倉本康弘
平尾勇造
大下嘉弘
林則博
天野浩貴
Original Assignee
涌永製藥株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 涌永製藥株式會社 filed Critical 涌永製藥株式會社
Publication of HK1047103A1 publication Critical patent/HK1047103A1/xx
Publication of HK1047103B publication Critical patent/HK1047103B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK02108684.2A 1999-07-01 2002-11-29 喹啉羧酸衍生物或其鹽 HK1047103B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18749299 1999-07-01
PCT/JP2000/004096 WO2001002390A1 (fr) 1999-07-01 2000-06-22 Derive d'acide quinolinecarboxylique et ses sels

Publications (2)

Publication Number Publication Date
HK1047103A1 HK1047103A1 (en) 2003-02-07
HK1047103B true HK1047103B (zh) 2005-04-08

Family

ID=16207019

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02108684.2A HK1047103B (zh) 1999-07-01 2002-11-29 喹啉羧酸衍生物或其鹽

Country Status (25)

Country Link
US (1) US6858625B1 (zh)
EP (1) EP1193266B1 (zh)
JP (1) JP3477465B2 (zh)
KR (1) KR100628414B1 (zh)
CN (1) CN1157389C (zh)
AT (1) ATE248162T1 (zh)
AU (1) AU766014B2 (zh)
BR (1) BR0012192A (zh)
CA (1) CA2376760C (zh)
CZ (1) CZ302033B6 (zh)
DE (1) DE60004846T2 (zh)
DK (1) DK1193266T3 (zh)
ES (1) ES2206257T3 (zh)
HK (1) HK1047103B (zh)
HU (1) HUP0201549A3 (zh)
IL (2) IL147043A0 (zh)
MX (1) MXPA02000103A (zh)
NO (1) NO321803B1 (zh)
NZ (1) NZ516201A (zh)
PT (1) PT1193266E (zh)
RU (1) RU2236408C2 (zh)
SK (1) SK285814B6 (zh)
TW (1) TW576832B (zh)
WO (1) WO2001002390A1 (zh)
ZA (1) ZA200110357B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3477466B2 (ja) 1999-09-02 2003-12-10 湧永製薬株式会社 キノリンカルボン酸誘導体又はその塩
US7172535B2 (en) * 2004-10-28 2007-02-06 Volmar John F Upper back exercise machine and method of use
WO2006054623A1 (ja) 2004-11-17 2006-05-26 Wakunaga Pharmaceutical Co., Ltd. 新規ピリドンカルボン酸誘導体又はその塩
KR20110091504A (ko) * 2008-09-24 2011-08-11 립-엑스 파마슈티칼즈, 인크. 퀴놀론 화합물의 제조 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO177302C (no) 1989-03-16 1995-08-23 Esteve Labor Dr Analogifremgangsmåte til fremstilling av terapeutisk aktive substituerte azetidinylkinolon(naftyridon)karboksylsyrederivater
CA2168764C (en) 1993-08-13 2000-01-18 Sung June Yoon Novel quinolone carboxylic acid derivatives
CN1105715C (zh) * 1995-09-22 2003-04-16 涌永制药株式会社 新型吡啶酮羧酸衍生物或其盐以及以它们为有效成分的抗菌剂
PT897919E (pt) 1996-04-19 2004-11-30 Wakunaga Pharma Co Ltd Novos derivados do acido piridonacarboxilico ou seus sais e agentes anti-bacterianos contendo-os como ingrediente activo
KR100516379B1 (ko) 1996-11-28 2005-09-26 와쿠나가 세이야쿠 가부시키 가이샤 신규 피리돈카르복실산 유도체 또는 그의 염 및 이를 유효 성분으로 하는 의약
DE19652239A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
JPH11292873A (ja) 1998-04-07 1999-10-26 Dainippon Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法およびその中間体

Also Published As

Publication number Publication date
IL147043A0 (en) 2002-08-14
SK285814B6 (sk) 2007-08-02
BR0012192A (pt) 2002-06-18
SK19162001A3 (sk) 2002-06-04
NO321803B1 (no) 2006-07-03
IL147043A (en) 2007-07-04
ZA200110357B (en) 2002-12-18
EP1193266A4 (en) 2002-08-14
DK1193266T3 (da) 2003-11-24
EP1193266A1 (en) 2002-04-03
TW576832B (en) 2004-02-21
MXPA02000103A (es) 2003-07-21
RU2236408C2 (ru) 2004-09-20
CN1157389C (zh) 2004-07-14
CA2376760C (en) 2008-11-25
US6858625B1 (en) 2005-02-22
DE60004846T2 (de) 2004-06-03
NO20016378D0 (no) 2001-12-27
WO2001002390A1 (fr) 2001-01-11
CN1358183A (zh) 2002-07-10
ATE248162T1 (de) 2003-09-15
CA2376760A1 (en) 2001-01-11
JP3477465B2 (ja) 2003-12-10
KR100628414B1 (ko) 2006-09-26
HUP0201549A2 (en) 2002-08-28
PT1193266E (pt) 2003-12-31
KR20020020733A (ko) 2002-03-15
NO20016378L (no) 2002-02-28
EP1193266B1 (en) 2003-08-27
ES2206257T3 (es) 2004-05-16
AU5567900A (en) 2001-01-22
CZ20014598A3 (cs) 2002-05-15
CZ302033B6 (cs) 2010-09-08
DE60004846D1 (de) 2003-10-02
NZ516201A (en) 2003-06-30
AU766014B2 (en) 2003-10-09
HK1047103A1 (en) 2003-02-07
HUP0201549A3 (en) 2003-11-28

Similar Documents

Publication Publication Date Title
DK0609606T3 (zh)
DK0657448T3 (da) •nbeholderfremgangsmåde til fremstilling af quinoloncarboxylsyrederivater
HK1097474A1 (en) Carbostyril derivatives for accelerating salivation
KR950011747B1 (en) Quinoline carboxylic acid perivatives
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
CY1112057T1 (el) Θεραπευτικος παραγων για διαταραχη επαρκειας τροφης στο στομαχι
HK1047103A1 (en) Quinolinecarboxylic acid derivative or salts thereof.
HUP0401562A2 (hu) Kinolinszármazékok és alkalmazásuk tumorellenes szerekként és ezeket tartalmazó gyógyászati készítmények
UA91549C2 (ru) Производные хинолина как антибактериальные агенты
JP3424038B2 (ja) 合成抗菌剤水性組成物
CY1110244T1 (el) Χαμηλης υγροσκοπικοτητας αριπιπραζολη ως φαρμακευτικη ουσια και μεθοδοι για την παρασκευη της
EP1219618A4 (en) QUINOLINECARBOXYLIC ACID DERIVATIVE OR ITS SALT
ES8506009A1 (es) Un procedimiento para la preparacion de derivados de oxacefalosporina
RU2002102491A (ru) Производные хинолинкарбоновой кислоты или их соли
RU2007122499A (ru) Новые производные пиридонкарбоновой кислоты или их соли
MXPA04000952A (es) Sales de derivados de acido 1,2,3-4-tetrahidro-isoquinolin-2-carboxilico.
GB0125658D0 (en) Medicaments

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100622